THE Therapeutic Goods Administration has issued infringement notices against a company called Eschoice Pty Ltd in relation to the alleged importation of unapproved therapeutic goods.
Australian Border Force officers seized the items, believed to be medicines and medical devices for use in cosmetic procedures, as part of Operation Antlia, a compliance initiative with the TGA which was initiated after a woman died from a cosmetic procedure at a Sydney clinic last year.
The TGA noted that Australian legislation "prohibits the import, export, manufacture and supply of therapeutic goods for human use that are not included in the Australian Register of Therapeutic Goods or otherwise the subject of an exemption, approval or authority".
Eschoice will pay penalties of more than $25,000 in the case, with the TGA also warning consumers to do their own research before undergoing procedures such as cosmetic injections, as they carry significant risks including blindness or even death - see tga.gov.au.
The above article was sent to subscribers in Pharmacy Daily's issue from 30 Nov 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 30 Nov 18
